Literature DB >> 27103093

Penile curvature: an update for management from 20 years experience in a high volume centre.

Francesco Sasso1, Matteo Vittori1, Alessandro D'Addessi1, Pier Francesco Bassi1.   

Abstract

Our aim was to review the literature and discuss about penile curvature in order to have an update for management after 20 years experience in the field.Penile curvature may be congenital or acquired. Congenital penile curvature is a relatively uncommon condition that may present in late adolescent or early adult life. The incidence is estimated to be 0.6 %. On the other side, acquired penile curvature has an overall prevalence of 0.5-13%. Three main factors seem to increase the risk of developing an acquired penile curvature, often related to Peyronie's disease: penile traumatism, genetic and familiar conditions and a history of diseases of the genital tract. In treating Peyronie's disease, no medical therapy is fully effective, and surgery remains the gold standard in cases of severe deformity and/or erectile disfunction. Peyronie's disease is associated with significant psychological stress for patients and their partners. Appropriate treatment should be individualized and tailored to the patient's goals and expectations. There is not the 'best' surgical technique and outcomes are satisfactory when proper treatment decisions are made.

Entities:  

Mesh:

Year:  2016        PMID: 27103093     DOI: 10.5301/uro.5000169

Source DB:  PubMed          Journal:  Urologia        ISSN: 0391-5603


  2 in total

1.  Clinical and penile Doppler outcomes using a modified, tourniquet free, Nesbit plication for severe Peyronie's disease.

Authors:  Vincenzo Maria Altieri; Francesco Greco; Rocca Carmela Lisanti; Barbara Altieri; Francesco Esperto; Luca Cindolo; Roberto Castellucci; Pier Andrea Della Camera; Giuseppe Massimo Sangiorgi; Vittore Verratti
Journal:  Transl Androl Urol       Date:  2021-07

2.  Is social media reliable as a source of information on Peyronie's disease treatment?

Authors:  Numan Baydilli; Ismail Selvi
Journal:  Int J Impot Res       Date:  2021-06-25       Impact factor: 2.896

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.